Accused bomber Ahmad Rahimi pleads not guilty in New Jersey case

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Ahmad Khan Rahami, 28, is the suspect of the Chelsea explosion in New York City on Saturday, September 17, 2016.

An attorney for Ahmad Rahimi, who is accused of planting bombs that detonated in New York and New Jersey, pleaded not guilty Tuesday on his client’s behalf to charges in connection with the shootout with police that lead to his capture.

Rahimi was arrested on Sept. 19 after the shootout with New Jersey police, which left him injured. Two police officers were also injured in the shootout. Rahimi limped into court and was helped into his seat Tuesday. His attorney, state public defender Peter Liguori waived a formal reading of the indictment.

Rahimi faces five counts of attempted murder of a law enforcement officer, multiple counts of second-, third-, and fourth-degree aggravated assault, second-degree unlawful possession of a weapon, second-degree possession of a weapon for an unlawful purpose and fourth-degree possession of a high-capacity magazine, according to a press release from the New Jersey Union County Prosecutor’s Office.

Prosecutors said they do not plan to extend a plea offer and asked the judge to move the case to trial as quickly as possible.

Liguori told the judge the defense received a large amount of discovery, evidence that may be used in the trial, and are in the process of going through the information.

The New Jersey Superior Court Judge Regina Caulfield scheduled a hearing for Feb. 28, at which time the judge plans to schedule a future trial date.

Rahimi also faces federal charges for the bombings in Manhattan’s Chelsea neighborhood and Seaside Heights, New Jersey, which occurred on the same day in September.

A court conference in the New York federal case was held on Monday but Rahimi did not appear in court — attorneys provided an update on the exchange of discovery. That trial is set to begin March 27.